SSB and synovial sarcoma: Recent studies have shown that SS may be associated with adverse pregnancy outcomes, and those antinuclear antibodies, anti-SSA, and anti-SSB in women during pregnancy may affect fetal development and increase the risk of adverse pregnancy outcomes such as miscarriage, congenital heart block, and preterm delivery.5